Pediatric Sepsis Score Stratification Faces Timing Ambiguity in Hydrocortisone Treatment Study
Researchers caution that overlapping measurement and treatment windows in pediatric sepsis studies may obscure whether hydrocortisone benefits specific risk subgroups.







